Literature DB >> 15564214

ARTIST (Asian regional tobacco industry scientist team): Philip Morris' attempt to exert a scientific and regulatory agenda on Asia.

E K Tong1, S A Glantz.   

Abstract

OBJECTIVE: To describe how the transnational tobacco industry has collaborated with local Asian tobacco monopolies and companies to promote a scientific and regulatory agenda.
METHODS: Analysis of previously secret tobacco industry documents.
RESULTS: Transnational tobacco companies began aggressively entering the Asia market in the 1980s, and the current tobacco industry in Asia is a mix of transnational and local monopolies or private companies. Tobacco industry documents demonstrate that, in 1996, Philip Morris led an organisation of scientific representatives from different tobacco companies called the Asian Regional Tobacco Industry Science Team (ARTIST), whose membership grew to include monopolies from Korea, China, Thailand, and Taiwan and a company from Indonesia. ARTIST was initially a vehicle for PM's strategies against anticipated calls for global smoke-free areas from a World Health Organization secondhand smoke study. ARTIST evolved through 2001 into a forum to present scientific and regulatory issues faced primarily by Philip Morris and other transnational tobacco companies. Philip Morris' goal for the organisation became to reach the external scientific and public health community and regulators in Asia.
CONCLUSION: The Asian tobacco industry has changed from an environment of invasion by transnational tobacco companies to an environment of participation with Philip Morris' initiated activities. With this participation, tobacco control efforts in Asia face new challenges as Philip Morris promotes and integrates its scientific and regulatory agenda into the local Asian tobacco industry. As the local Asian tobacco monopolies and companies can have direct links with their governments, future implementation of effective tobacco control may be at odds with national priorities.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15564214      PMCID: PMC1766165          DOI: 10.1136/tc.2004.009001

Source DB:  PubMed          Journal:  Tob Control        ISSN: 0964-4563            Impact factor:   7.552


  32 in total

1.  Why trade and investment liberalisation may threaten effective tobacco control efforts.

Authors:  C Callard; H Chitanondh; R Weissman
Journal:  Tob Control       Date:  2001-03       Impact factor: 7.552

2.  Tobacco control in an era of trade liberalisation.

Authors:  D Bettcher; I Shapiro
Journal:  Tob Control       Date:  2001-03       Impact factor: 7.552

3.  Consolidation in the tobacco industry.

Authors:  R Hammond
Journal:  Tob Control       Date:  1998       Impact factor: 7.552

4.  Multicenter case-control study of exposure to environmental tobacco smoke and lung cancer in Europe.

Authors:  P Boffetta; A Agudo; W Ahrens; E Benhamou; S Benhamou; S C Darby; G Ferro; C Fortes; C A Gonzalez; K H Jöckel; M Krauss; L Kreienbrock; M Kreuzer; A Mendes; F Merletti; F Nyberg; G Pershagen; H Pohlabeln; E Riboli; G Schmid; L Simonato; J Trédaniel; E Whitley; H E Wichmann; C Winck; P Zambon; R Saracci
Journal:  J Natl Cancer Inst       Date:  1998-10-07       Impact factor: 13.506

5.  Why review articles on the health effects of passive smoking reach different conclusions.

Authors:  D E Barnes; L A Bero
Journal:  JAMA       Date:  1998-05-20       Impact factor: 56.272

6.  Tobacco industry efforts subverting International Agency for Research on Cancer's second-hand smoke study.

Authors:  E K Ong; S A Glantz
Journal:  Lancet       Date:  2000-04-08       Impact factor: 79.321

7.  Political economy of tobacco control in Thailand.

Authors:  S Chantornvong; D McCargo
Journal:  Tob Control       Date:  2001-03       Impact factor: 7.552

8.  The opium wars revisited as US forces tobacco exports in Asia.

Authors:  T T Chen; A E Winder
Journal:  Am J Public Health       Date:  1990-06       Impact factor: 9.308

9.  Learning from Philip Morris: Japan Tobacco's strategies regarding evidence of tobacco health harms as revealed in internal documents from the American tobacco industry.

Authors:  Kaori Iida; Robert N Proctor
Journal:  Lancet       Date:  2004-05-29       Impact factor: 79.321

10.  "Marriage to a smoker" may not be a valid marker of exposure in studies relating environmental tobacco smoke to risk of lung cancer in Japanese non-smoking women.

Authors:  P N Lee
Journal:  Int Arch Occup Environ Health       Date:  1995       Impact factor: 3.015

View more
  9 in total

1.  German tobacco industry's successful efforts to maintain scientific and political respectability to prevent regulation of secondhand smoke.

Authors:  A Bornhäuser; J McCarthy; S A Glantz
Journal:  Tob Control       Date:  2006-04       Impact factor: 7.552

Review 2.  The vector of the tobacco epidemic: tobacco industry practices in low and middle-income countries.

Authors:  Sungkyu Lee; Pamela M Ling; Stanton A Glantz
Journal:  Cancer Causes Control       Date:  2012-02-28       Impact factor: 2.506

Review 3.  Asian herbal-tobacco cigarettes: "not medicine but less harmful"?

Authors:  Aiyin Chen; Stanton Glantz; Elisa Tong
Journal:  Tob Control       Date:  2007-04       Impact factor: 7.552

4.  Relationship between the Chinese tobacco industry and academic institutions in China.

Authors:  Quan Gan; Stanton A Glantz
Journal:  Tob Control       Date:  2010-10-15       Impact factor: 7.552

5.  "Efforts to Reprioritise the Agenda" in China: British American Tobacco's Efforts to Influence Public Policy on Secondhand Smoke in China.

Authors:  Monique E Muggli; Kelley Lee; Quan Gan; Jon O Ebbert; Richard D Hurt
Journal:  PLoS Med       Date:  2008-12-23       Impact factor: 11.069

6.  Tobacco industry globalization and global health governance: towards an interdisciplinary research agenda.

Authors:  Kelley Lee; Jappe Eckhardt; Chris Holden
Journal:  Palgrave Commun       Date:  2016-07-05

7.  "A good personal scientific relationship": Philip Morris scientists and the Chulabhorn Research Institute, Bangkok.

Authors:  Ross Mackenzie; Jeff Collin
Journal:  PLoS Med       Date:  2008-12-23       Impact factor: 11.069

8.  The Tobacco Industry's Abuse of Scientific Evidence and Activities to Recruit Scientists During Tobacco Litigation.

Authors:  Sungkyu Lee
Journal:  J Prev Med Public Health       Date:  2016-01

9.  A Systematic Review of Tobacco Industry Tactics in Southeast Asia: Lessons for Other Low- And MiddleIncome Regions.

Authors:  Gianna Gayle Herrera Amul; Grace Ping Ping Tan; Yvette van der Eijk
Journal:  Int J Health Policy Manag       Date:  2021-06-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.